As we close out 2023, we look back on the year and reflect on the variety of ways Cryoport Systems was able to support our biopharma, reproductive medicine, and animal health clients. From acquisitions & expanded solutions offerings to a company rebrand, we thank our teams around the world who bring their commitment to success to every aspect of each client’s journey.
Here are some of Cryoport System’s highlights from 2023:
January
- New Strategic Partnership with Syneos Health.
- Sydney Global Logistics Center Opens.
February
- Cryoport Announced Our Support For 654 Global Clinical Trials and 10 Commercial Therapies.
- Celebrated 10 Years Of Supporting Animal Health Partner Zoetis.
March
- Announced Multi-Year Agreement With Inception Fertility.
April
- Cryoport Signed New Supply Chain Agreement With Boston IVF.
May
- Announced A Record 20% Revenue Growth YoY (2022 vs 2023)
June
- Cryoport Is Selected As The Exclusive Supply Chain Solutions Provider By IVFAustralia.
July
- First Remote Cryoshuttle® Local Pickup & Delivery Service Officially Available In The Metro Washington DC Area.
August
- Announced A YoY New Increase of 42 New Clinical Trials Supported By Cryoport (A Record Total 668 Clinical Trials)
September
- Cryoport Wins Best Cell & Gene Therapy Supplier Award – Cryogenic Storage at the Asia Pacific Cell & Gene Excellence Awards 2023.
October
- New Partnership with Be The Match BioTherapies®.
- New Strategic Collaboration with Catapult.
- New Multi-Year Agreement with Monash IVF.
November
- Cryoport Continues Its Expansion In The European Market By Acquiring Tech4med.
December
- Cryoport Unveiled Our New Look With A Company Rebrand!